79Indexed trials
Market Rank #26 · Evidence Tier A
Mexico
Neuroscience Intelligence
Mexico neuroscience intelligence: 79 indexed trials, 9 institutions, research score 30.00.
21Recruiting
9Research institutions
30.0Research score
Evidence profile
45Sponsors
20Disease areas
0Institution works
0Institution citations
Model signals
Opportunity 30 · ML priority 30 · Confidence 100 · Evidence 30.0
These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.
Leading disease areas
alzheimers13trials
epilepsy12trials
parkinsons8trials
depression5trials
schizophrenia5trials
other_neurology3trials
adhd2trials
anxiety2trials
autism2trials
migraine_headache2trials
Leading indexed sponsors
Hoffmann-La Roche7trials
Pfizer6trials
Merck Sharp & Dohme LLC6trials
Eli Lilly and Company5trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3trials
UCB Pharma3trials
Washington University School of Medicine3trials
Bayer2trials
Novartis Pharmaceuticals2trials
GlaxoSmithKline2trials